Retatrutide Reduces Knee Osteoarthritis Pain and Body Weight
Two late-stage clinical trials published on November 8, 2026, in The New England Journal of Medicine show that the investigational triple-agonist drug retatrutide significantly reduces knee osteoarthritis pain and physical function scores while driving substantial weight loss in adults with obesity. Trials Test Retatrutide for Knee Pain The international trials, named TRIUMPH-4 and TRIUMPH-1-OA, evaluated … Read more